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In the US presence of autism spectrum disorder (ASD) is rising.
A main symptom of ASD is stereotypic behavior, which is rigid,
repetitive, and functionless. Despite its potential to disrupt daily
functioning and routines, there is no effective treatment.
The keto diet (KD), a low-carb high-fat diet, has gained
increased efficacy in treating ASD.
FVB mice are genetically predisposed to perform stereotypic
behavior manifested in a circling movement pattern.
Adenosine is involved in energy regulation and typically inhibits
motor activity. Adenosine 2A (A2A) receptors are expressed in
the indirect basal ganglia pathway. Here, we hypothesized
administration of an A2A receptor agonist would decrease
repetitive circling.

Results

Figures

●

●
●
●
●
Figure 1. Baseline locomotor activity prior to the
introduction of adenosine and diet change. Mice
previously on KD showed reduced activity, as
indicated by fewer beam breaks.

Figure 2. Adenosine reduced locomotor
activity in both groups. KD mice had
decreased locomotion activity compared to
the SD group.
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Mice were used from an earlier study analyzing the effect of KD
on locomotion. Here, mice remained in their previous diet group
and were again fed either KD or a standard diet (SD).
Stereotypic behavior was recorded weekly through an
automated locomotor test, consisting of a 20 minute
habituation period, 30 minute baseline followed by a 60 minute
test.
During week 1, pre-experimental conditions (Before KD &
adenosine) were recorded. Accordingly, KD and adenosine were
not employed. Mice were instead given a 0.2 mg peanut oil
injection following the baseline measurement.
On weeks 2, 3, & 4, half of the mice began KD while the others
remained on SD. After the baseline, an A2A receptor agonist was
administered at 1 ml/g, and movement was recorded.
For week 5, all the mice returned to SD, and a peanut oil
injection was administered after the baseline measurement.
Throughout each week, the weight of the mice was monitored
due to the potential effect of diet.

During week 1 (baseline), stereotypic behavior
was lower in mice previously on KD compared
to those never on KD.
Group differences show the persistent effect
of KD on lessening repetitive behaviors.
After the A2A receptor agonist injection,
locomotion for all mice decreased.
During week 2 there were differences due to
diet.
Results indicate that the A2A receptor agonist
reduces repetitive behavior but does not
synergistically interact with KD.

Limitation/ Future
Directions
●

Figure 3. Adenosine reduced locomotor activity
in both groups. There was diet differences
between groups, as KD mice had signiﬁcantly
reduced locomotion activity compared to the
SD group.

Figure 4. Adenosine collectively
decreased locomotion activity, and KD
mice had reduced movement
compared to SD mice
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Figure 5. After removing KD and injecting
with peanut oil, locomotor activity
increased for both groups; however, mice
previously on KD remained less active
than SD mice
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Future directions include repeating our study
using the same conditions to increase the
validity of results and further assess which
mechanisms in the brain allow for adenosine
and KD to attenuate stereotypic behavior.
All conditions should remain the same except
for the subject group. In order to assess for sex
differences, a larger sample size should be
utilized.
We would like to investigate both the
adenosine A1 and 2A receptor agonists, which
have previously been shown to reduce
spinning with coadministration.
Potential to reevaluate/ experiment with
different drug administration dosages.

